Influenza Resource Package (IRP)
The IRP is a technical resource package on seasonal influenza and vaccination is to assist NITAG working groups in the preparation of their technical dossier for influenza vaccine policy development. It presents a summary of global, regional and, for certain issues, local evidence that NITAG working groups can use to assist in development of recommendations, and incorporate into a technical dossier on seasonal influenza vaccination.
This resource package was developed in 2017-2018 to support regional and country efforts to develop seasonal influenza vaccination policies.
Influenza Resources (Influenza Focus)
Influenza 101 – updated Sept 2022
This training was developed by the Influenza Division at CDC and is intended as an introduction to the influenza virus, its epidemiology, and vaccines.
Influenza Vaccines – Efficacy & Safety – updated Sept 2022
This training was developed by the Influenza Division at CDC and is intended as an introduction to influenza vaccines and their safety and efficacy.
Evolution of US Influenza Vaccine Policy – updated Sept 2022
This presentation by the Influenza Division shows the evolution of influenza vaccine policy in the United States. It is a good example of how recommendations are developed and how a NITAG uses evidence to make recommendations
WHO SAGE Recommendations
This document from the WHO Strategic Advisory Group of Experts (SAGE) on Immunization provides interim recommendations for influenza vaccination prioritization of risk groups for seasonal influenza vaccination during the COVID-19 pandemic. It also provides programmatic considerations for national authorities planning and conducting their influenza vaccination programs, as well as research considerations to address current knowledge gaps.
WHO Influenza Toolkit
The seasonal influenza vaccination toolkit includes training, guidance, campaign materials, and other useful resources.These resources are intended to support Ministry of Health officials, WHO staff, vaccinators, health workers, researchers, and other stakeholders.
United States Advisory Committee on Immunization Practices (ACIP) influenza vaccine recommendations (2022)
ACIP is the US NITAG and provides advice and guidance regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).The link provides the current influenza vaccine recommendations for the United States.